-
Je něco špatně v tomto záznamu ?
Coated capsules for drug targeting to proximal and distal part of human intestine
K. Dvořáčková, M. Rabišková, J. Gajdziok, D. Vetchý, J. Muselík, J. Bernatoniene, M. Bajerová, P. Drottnerová
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10222
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Free Medical Journals
od 1998
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- ileum metabolismus MeSH
- koncentrace vodíkových iontů MeSH
- kyseliny polymethakrylové aplikace a dávkování MeSH
- lidé MeSH
- rozpustnost MeSH
- systémy cílené aplikace léků MeSH
- tobolky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Coated hard capsules are becoming increasingly important for a number of reasons such as administration of new active ingredients, oral vaccination, colon drug delivery or their use in preclinical and clinical trials. The independency of coating composition on capsules filling is the major advantage of this dosage form. In our study, two types of hard capsules (gelatin and hypromellose) were coated by non-aqueous solutions of Eudragit L and S 12.5, respectively, to achieve intestinal and distal ileic drug delivery. Gelatin hard capsules were coated with Eudragit film either directly or using hydroxypropyl cellulose sub-coating prior to the final coating. Hypromellose capsules were coated directly. Coated capsules were evaluated for coating thickness by optical microscope and for dissolution in different pH media. Gelatin capsules do not seem to be suitable for direct coating with Eudragit due to insufficient film adhesion to the smooth capsule surface and a brittleness of formed films. These problems can be solved by hydroxypropyl celullose interlayer application. Hypromellose hard capsules could be directly easily coated with both Eudragit solutions. Dissolution of caffeine from coated capsules showed the potency for enteric delivery in gelatin capsules with interlayer and Eudragit L film in 7.5 and 10.0% concentrations and in hypromellose capsules coated with EudragitL in 5-17.5% coating levels. Gelatine capsules with interlayer and 10% Eudragit S film and hypromellose capsules only with high coating level (20%) provided potential distal ileum targeting of incorporated drug. Eudragit S film sprayed onto hypromellose capsules surface was brittle especially in the junction zone between capsule cap and body. Better plasticity of Eudragit S coating could be probably achieved using a different plasticizer.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025098
- 003
- CZ-PrNML
- 005
- 20221005163027.0
- 007
- ta
- 008
- 120816s2010 pl f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20369797
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Dvořáčková, Kateřina, $d 1973- $7 xx0138801 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
- 245 10
- $a Coated capsules for drug targeting to proximal and distal part of human intestine / $c K. Dvořáčková, M. Rabišková, J. Gajdziok, D. Vetchý, J. Muselík, J. Bernatoniene, M. Bajerová, P. Drottnerová
- 520 9_
- $a Coated hard capsules are becoming increasingly important for a number of reasons such as administration of new active ingredients, oral vaccination, colon drug delivery or their use in preclinical and clinical trials. The independency of coating composition on capsules filling is the major advantage of this dosage form. In our study, two types of hard capsules (gelatin and hypromellose) were coated by non-aqueous solutions of Eudragit L and S 12.5, respectively, to achieve intestinal and distal ileic drug delivery. Gelatin hard capsules were coated with Eudragit film either directly or using hydroxypropyl cellulose sub-coating prior to the final coating. Hypromellose capsules were coated directly. Coated capsules were evaluated for coating thickness by optical microscope and for dissolution in different pH media. Gelatin capsules do not seem to be suitable for direct coating with Eudragit due to insufficient film adhesion to the smooth capsule surface and a brittleness of formed films. These problems can be solved by hydroxypropyl celullose interlayer application. Hypromellose hard capsules could be directly easily coated with both Eudragit solutions. Dissolution of caffeine from coated capsules showed the potency for enteric delivery in gelatin capsules with interlayer and Eudragit L film in 7.5 and 10.0% concentrations and in hypromellose capsules coated with EudragitL in 5-17.5% coating levels. Gelatine capsules with interlayer and 10% Eudragit S film and hypromellose capsules only with high coating level (20%) provided potential distal ileum targeting of incorporated drug. Eudragit S film sprayed onto hypromellose capsules surface was brittle especially in the junction zone between capsule cap and body. Better plasticity of Eudragit S coating could be probably achieved using a different plasticizer.
- 650 _2
- $a tobolky $7 D002214
- 650 _2
- $a systémy cílené aplikace léků $7 D016503
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a ileum $x metabolismus $7 D007082
- 650 _2
- $a kyseliny polymethakrylové $x aplikace a dávkování $7 D011109
- 650 _2
- $a rozpustnost $7 D012995
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rabišková, Miloslava, $d 1951- $7 mzk2005290121
- 700 1_
- $a Gajdziok, Jan $7 xx0126570
- 700 1_
- $a Vetchý, David, $d 1972- $7 mzk2006368163
- 700 1_
- $a Muselík, Jan $7 xx0100243
- 700 1_
- $a Bernatoniene, Jurga $u Department of Drug Technology, Faculty of Pharmacy, Kaunas University of Medicine, Lithuania
- 700 1#
- $a Kejdušová, Martina. $7 xx0176149
- 700 1#
- $a Drottnerová, Pavlína. $7 _AN070825
- 773 0_
- $w MED00000128 $t Acta poloniae pharmaceutica $x 0001-6837 $g Roč. 67, č. 2 (2010), s. 191-199
- 856 41
- $u http://www.ptfarm.pl/pub/File/Acta_Poloniae/2010/2/191.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20221005163022 $b ABA008
- 999 __
- $a ok $b bmc $g 947140 $s 782444
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 67 $c 2 $d 191-199 $i 0001-6837 $m Acta poloniae pharmaceutica $n Acta Pol Pharm $x MED00000128
- GRA __
- $a NS10222 $p MZ0
- LZP __
- $a Pubmed-20120816/10/02